Dr. Saqib Razzaque, MD

Dr. Razzaque practices at El Centro Regional Medical Center in El Centro, California, part of City of El Centro.

Dr. Razzaque's NPI, 1437398591, was assigned on February 13, 2009. Dr. Razzaque graduated from Rawalpindi Medical College in 2001. Dr. Razzaque's California license number on file is A127157.

Dr. Razzaque's primary practice is El Centro Regional Medical Center, at 1415 Ross Avenue, El Centro, CA 92243 in Imperial County. The practice phone is (760) 339-7100.

Dr. Razzaque's primary practice is El Centro Regional Medical Center in El Centro, California, part of City of El Centro. Dr. Razzaque is also affiliated with Pioneers Memorial Hospital. The medical group on file is New Era Oncology. Dmand AI also links Dr. Razzaque to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Razzaque practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Razzaque's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Razzaque is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Razzaque's licenses on file in 3 states: California, Florida and Minnesota.

Dmand AI lists arthritis, asthma, chronic anemia, chronic diabetes, chronic hypertension, chronic kidney disease, fluid and electrolyte imbalances and neutropenia among the conditions Dr. Razzaque treats.

CMS data shows 2,182 Medicare services from Dr. Razzaque across 12 procedure codes in 2024, for 506 Medicare patients. Medicare paid $146,479 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 506 Medicare patients who saw Dr. Razzaque in 2024. The largest group is 65 to 74, with 224 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 78% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Razzaque's median patient age at 71, with 61% women.

In 2024, Dr. Razzaque wrote 1,564 Medicare Part D claims for 225 patients. 79% of them were for generic drugs. CMS names the drug for 1,373 of them, across 37 drugs with 11 or more claims each, at $4,173,747 in total drug cost. In 2023, CMS named 1,302 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 39 out of 100 for Dr. Razzaque for performance year 2024, reported individually. Dr. Razzaque accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Razzaque as offering telehealth.

Dmand AI links 2 papers to Dr. Razzaque in 2021. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Razzaque's most frequent co-authors are Michael Bouvet, MD, Minsig Choi, MD and Paul Timothy Fanta, MD.

CMS Open Payments shows 52 general payments to Dr. Razzaque from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Bristol-Myers Squibb Company paid the most, $297.

Dr. Razzaque graduated from Rawalpindi Medical College in 2001.

Dr. Razzaque is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.